FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048375087> ?p ?o ?g. }

• W3048375087 abstract "Abstract To describe the epidemiological and clinical characteristics of patients with Corona Virus Disease 2019 (COVID-19) in Beijing. To analyze the application of corticosteroids in patients with severe pneumonia. We collected information on demographic characteristics, exposure history, clinical characteristics, corticosteroids use, and outcomes of the 65 confirmed cases of COVID-19 at Fifth Medical Center of PLA General Hospital from Jan 20 to Feb 23, 2020. The final follow-up date observed was April 15th, 2020. The number of patients with mild, general, severe, and critical type were 10 (15.38%), 32 (49.23%), 8 (12.31%), and 15 (23.08%), respectively. The median incubation period was 6 days. Notable outliers were 1 patient at 16 days and 1 patient at 21 days. In lymphocyte subgroup analysis, decreases in total, T, CD4, and CD8 lymphocytes were more common as the disease worsened (All P < 0.05). Methylprednisolone (mPSL) was applied to 31 (47.69%) patients with pneumonia, including 10 (31.25%) general, 8 (100%) severe, and 13 (86.67%) critical patients, respectively. Corticosteroids inhibited Interleukin-6(IL-6) production ( P = 0.0215) but did not affect T lymphocyte ( P = 0.0796). There was no significant difference between patients using lower dose (≤ 2 mg/kg day) and higher dose (> 2 mg/kg day) mPSL in inhibiting IL-6 production ( P = 0.5856). Thirty of 31 patients (96.77%) had stopped mPSL due to improvement of pneumonia. Virus RNA clearance time lengthened with disease progression ( P = 0.0001). In general type, there was no significant difference in virus clearance time between patients with (15, 12–19 days) and without (14.5, 11–18 days) ( P = 0.7372) mPSL use. Lymphocyte, especially T lymphocyte, in severe and critical patients showed a dramatic decrease. Application of lower dose corticosteroids (≤ 2 mg/kg day) could inhibit IL-6 production (a representative of cytokines) as effectively as a higher dose. Proper use corticosteroids in general type patients did not delay virus clearance." @default.
• W3048375087 created "2020-08-18" @default.
• W3048375087 creator A5000794898 @default.
• W3048375087 creator A5012686016 @default.
• W3048375087 creator A5014844829 @default.
• W3048375087 creator A5015886236 @default.
• W3048375087 creator A5022613513 @default.
• W3048375087 creator A5024923990 @default.
• W3048375087 creator A5024956553 @default.
• W3048375087 creator A5031675980 @default.
• W3048375087 creator A5043237595 @default.
• W3048375087 creator A5050715772 @default.
• W3048375087 creator A5056314971 @default.
• W3048375087 creator A5060361805 @default.
• W3048375087 creator A5061154616 @default.
• W3048375087 creator A5066803400 @default.
• W3048375087 creator A5079459081 @default.
• W3048375087 creator A5082681535 @default.
• W3048375087 creator A5086877102 @default.
• W3048375087 creator A5089737520 @default.
• W3048375087 date "2020-08-13" @default.
• W3048375087 modified "2023-09-27" @default.
• W3048375087 title "Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019" @default.
• W3048375087 cites W1693866076 @default.
• W3048375087 cites W1803784511 @default.
• W3048375087 cites W1977050884 @default.
• W3048375087 cites W1995121548 @default.
• W3048375087 cites W2026274122 @default.
• W3048375087 cites W2054076340 @default.
• W3048375087 cites W2062817591 @default.
• W3048375087 cites W2070463916 @default.
• W3048375087 cites W2071496056 @default.
• W3048375087 cites W2129542667 @default.
• W3048375087 cites W2465777822 @default.
• W3048375087 cites W2555838982 @default.
• W3048375087 cites W2586093485 @default.
• W3048375087 cites W2610456504 @default.
• W3048375087 cites W2611428787 @default.
• W3048375087 cites W2769689735 @default.
• W3048375087 cites W2791373299 @default.
• W3048375087 cites W3001118548 @default.
• W3048375087 cites W3002539152 @default.
• W3048375087 cites W3003573988 @default.
• W3048375087 cites W3003668884 @default.
• W3048375087 cites W3003951199 @default.
• W3048375087 cites W3004239190 @default.
• W3048375087 cites W3005905966 @default.
• W3048375087 cites W3006873276 @default.
• W3048375087 cites W3016288338 @default.
• W3048375087 cites W3016585006 @default.
• W3048375087 cites W3022970339 @default.
• W3048375087 cites W3025465106 @default.
• W3048375087 cites W3165656738 @default.
• W3048375087 doi "https://doi.org/10.1038/s41598-020-70387-2" @default.
• W3048375087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7426825" @default.
• W3048375087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32792492" @default.
• W3048375087 hasPublicationYear "2020" @default.
• W3048375087 type Work @default.
• W3048375087 sameAs 3048375087 @default.
• W3048375087 citedByCount "27" @default.
• W3048375087 countsByYear W30483750872020 @default.
• W3048375087 countsByYear W30483750872021 @default.
• W3048375087 countsByYear W30483750872022 @default.
• W3048375087 countsByYear W30483750872023 @default.
• W3048375087 crossrefType "journal-article" @default.
• W3048375087 hasAuthorship W3048375087A5000794898 @default.
• W3048375087 hasAuthorship W3048375087A5012686016 @default.
• W3048375087 hasAuthorship W3048375087A5014844829 @default.
• W3048375087 hasAuthorship W3048375087A5015886236 @default.
• W3048375087 hasAuthorship W3048375087A5022613513 @default.
• W3048375087 hasAuthorship W3048375087A5024923990 @default.
• W3048375087 hasAuthorship W3048375087A5024956553 @default.
• W3048375087 hasAuthorship W3048375087A5031675980 @default.
• W3048375087 hasAuthorship W3048375087A5043237595 @default.
• W3048375087 hasAuthorship W3048375087A5050715772 @default.
• W3048375087 hasAuthorship W3048375087A5056314971 @default.
• W3048375087 hasAuthorship W3048375087A5060361805 @default.
• W3048375087 hasAuthorship W3048375087A5061154616 @default.
• W3048375087 hasAuthorship W3048375087A5066803400 @default.
• W3048375087 hasAuthorship W3048375087A5079459081 @default.
• W3048375087 hasAuthorship W3048375087A5082681535 @default.
• W3048375087 hasAuthorship W3048375087A5086877102 @default.
• W3048375087 hasAuthorship W3048375087A5089737520 @default.
• W3048375087 hasBestOaLocation W30483750871 @default.
• W3048375087 hasConcept C107130276 @default.
• W3048375087 hasConcept C126322002 @default.
• W3048375087 hasConcept C2777914695 @default.
• W3048375087 hasConcept C2779134260 @default.
• W3048375087 hasConcept C2780372218 @default.
• W3048375087 hasConcept C3008058167 @default.
• W3048375087 hasConcept C524204448 @default.
• W3048375087 hasConcept C71924100 @default.
• W3048375087 hasConcept C90924648 @default.
• W3048375087 hasConceptScore W3048375087C107130276 @default.
• W3048375087 hasConceptScore W3048375087C126322002 @default.
• W3048375087 hasConceptScore W3048375087C2777914695 @default.
• W3048375087 hasConceptScore W3048375087C2779134260 @default.
• W3048375087 hasConceptScore W3048375087C2780372218 @default.
• W3048375087 hasConceptScore W3048375087C3008058167 @default.
• W3048375087 hasConceptScore W3048375087C524204448 @default.

• next